Rituximab Monotherapy in the Management of a Rare Case of an HIV Associated Lymphoproliferative Disorder
Background. Castleman’s disease (CD), also known as angiofollicular node hyperplasia, is a rare heterogenous lymphoproliferative disorder. This disease exists as two distinct entities: a localized or unicentric CD (UCD) which has a more benign clinical course and multicentric CD (MCD) which is a sys...
Saved in:
Main Authors: | Jason Hew, Fauzia Rana, Louise Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-01-01
|
Series: | Case Reports in Oncological Medicine |
Online Access: | http://dx.doi.org/10.1155/2017/5235163 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
HHV-8-Associated Lymphoproliferative Disorders and Pathogenesis in an HIV-Positive Patient
by: Carlo Guerrero, et al.
Published: (2019-01-01) -
HHV8/EBV Coinfection Lymphoproliferative Disorder: Rare Entity with a Favorable Outcome
by: Dhouha Bacha, et al.
Published: (2017-01-01) -
Methotrexate-Associated Lymphoproliferative Disorder in a Patient with Psoriasis: A Case Report and Review of the Literature
by: Carolina Afonso, et al.
Published: (2022-01-01) -
Late-Onset Posttransplant Lymphoproliferative Disorder Results in Jejunal Stricture Managed with Endoscopic Dilation
by: Steven Park, et al.
Published: (2021-01-01) -
Metagenomic analysis of DNA viruses from posttransplant lymphoproliferative disorders
by: Vikas R. Dharnidharka, et al.
Published: (2019-03-01)